Nymox Pharmaceutical
NYMX
#9604
Rank
$18.25 M
Marketcap
Country
$0.20
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -$2.17 Million USD

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -$6.53 Million USD, an increase over its 2021 earnings that were of -$12.49 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -$2.17 Million-66.89%
2022 -$6.53 Million-47.71%
2021 -$12.49 Million6.61%
2020 -$11.71 Million-10.91%
2019 -$13.14 Million24.24%
2018 -$10.58 Million-20.03%
2017 -$13.23 Million2.71%
2016 -$12.88 Million-63.86%
2015 -$35.64 Million674.44%
2014 -$4.61 Million-6.11%
2013 -$4.91 Million-35.66%
2012 -$7.62 Million-20.76%
2011 -$9.62 Million38.33%
2010 -$6.95 Million35.59%
2009 -$5.13 Million11.8%
2008 -$4.59 Million-12.94%
2007 -$5.27 Million8.85%
2006 -$4.84 Million36.5%
2005 -$3.55 Million-4.4%
2004 -$3.71 Million-14.58%
2003 -$4.34 Million
2001 -$3.19 Million-20.54%
2000 -$4.01 Million21.72%
1999 -$3.3 Million-25.56%
1998 -$4.43 Million101.3%
1997 -$2.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$6.77 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.22 Billion 55,985.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.11 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.15 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.39 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA